11 Amendments of Valentinas MAZURONIS related to 2014/2207(INI)
Amendment 7 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Aa. whereas the key to the quality of healthcare lies in patient safety, the essential elements of which are a healthcare culture and the management of adverse events;
Amendment 10 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas 23% of Europeans have said that they themselves or their family members have been personally affected by the direct result of a medical error in hospital;
Amendment 27 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas 30%-50% of patients do not take the medicines prescribed for them by doctors or do not take them as directed by the doctor’s prescription;
Amendment 32 #
Motion for a resolution
Recital J
Recital J
J. whereas HAIs are a major public health problem in the Member States (some 4.1 million patientsaccording to figures compiled by the European Centre for Disease Prevention and Control, 1 in 20 hospital in-patients, on average, suffers from an HAI in the EU annually, that is to say, 4.1 million patients annually, and every year 37 000 people in the EU die as a result of an HAI, although 20%-30 % of these infections are considered to be preventable by intensive hygiene and control programmes), and this places a heavy burden on limited health service budgets;
Amendment 93 #
Motion for a resolution
Recital R a (new)
Recital R a (new)
Ra. whereas the fast-growing health (medical) tourism is making new demands, in terms of safety and quality, on the national healthcare systems of the countries concerned;
Amendment 166 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Invites the Member States to improve their reporting systems for adverse events and medical errors by developingincorporating subsystems enabling failings to be recorded and lessons to be learnt from them, and oriented towards preventing such incidents, and, in addition, to lay down measures that encourage accurate, blame-free and anonymous reporting by health professionals and patients;
Amendment 196 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Points out that antibiotic resistance often holds up treatment with the right antibiotics and that, when they are given the wrong antibiotics or treatment starts too late, patients with serious infectious diseases suffer grave complications which in some cases can be fatal;
Amendment 205 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Calls for greater attention to be focused on the development of new antimicrobial agents aimed at new targets and for encouragement to be given to the use of bacteriostatic antibiotics, which do not kill pathogens, but merely inhibit their proliferation, making pathogens less likely to become resistant;
Amendment 223 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Member States to promote the responsible and sensible use in human medicine of all antimicrobial agents and in particular antibiotics, bearing in mind that improper use of antibiotics, especially in hospitals, is one of the main contributory factors in the emergence of antibiotic resistance;
Amendment 251 #
Motion for a resolution
Paragraph 22 – point d
Paragraph 22 – point d
d) monitor antibiotic resistance and the use of antibiotics in hospitals and, on the basis of the findings, make recommendations for the empirical treatment of seriously ill patients, and ensure that antibiotics are used in hospitals only for the correct indications, at the correct dose and for the shortest duration possible as recommended by evidence- based guidelines;
Amendment 320 #
Motion for a resolution
Paragraph 26
Paragraph 26
26. Calls on the Commission and the Member States to further engage in a dialogue with all stakeholders, increase interoperability between institutions, sectors, and States in healthcare service provision, and develop a coordinated, comprehensive and sustainable EU strategy for patient safety, as well as to put forward concrete solutions to be implemented at EU, national, regional, local and/or primary care levels;